12 Matching Annotations
  1. Oct 2025
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Bone-Induced Her2 Promotes Secondary Metastasis in HR+/Her2− Breast Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11964846/
  3. Oct 2023
  4. 52.53.155.43 52.53.155.43
    bqad159-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/fadb698104ccd541263e8069783171593188288f/bqad159-html.html
  5. 52.53.155.43 52.53.155.43
    ccr-23-0103-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/05abf3a0903b8473a428373dc7a2f791e1da90bb/ccr-23-0103-html.html
  6. Aug 2023
  7. www.biorxiv.org www.biorxiv.org
    Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2023.08.21.554116v1
  8. Jul 2023
  9. 52.53.155.43 52.53.155.43
    ccr-23-0103-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/05abf3a0903b8473a428373dc7a2f791e1da90bb/ccr-23-0103-html.html
  10. May 2022
  11. aacrjournals.org aacrjournals.org
    Increased microtubule growth triggered by microvesicle-mediated paracrine signaling is required for melanoma cancer cell invasion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/2/5/366/698979/Increased-Microtubule-Growth-Triggered-by
  12. Mar 2022
  13. www.sciencedirect.com www.sciencedirect.com
    Active immunization with a Her-2/neu-targeting Multi-peptide B cell vaccine prevents lung metastases formation from Her-2/neu breast cancer in a mouse model
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1936523322000407
  14. Sep 2021
  15. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Activity and mechanism of acquired resistance to tarloxotinib in HER2 mutant lung cancer: an in vitro study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8435395/
  16. Jun 2021
  17. www.sciencedirect.com www.sciencedirect.com
    Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610821002841
  18. Feb 2021
  19. mct.aacrjournals.org mct.aacrjournals.org
    Predictive and Pharmacodynamic Biomarkers of Response to the Phosphatidylinositol 3-Kinase Inhibitor Taselisib in Breast Cancer Preclinical Models
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    mct.aacrjournals.org/content/19/1/292
  20. Sep 2020
  21. www.sciencedirect.com www.sciencedirect.com
    Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610819305835
  22. Nov 2018
  23. www.sciencedirect.com www.sciencedirect.com
    Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2451945618301193